Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intuitive Machines (LUNR) vs Merck & Co., Inc. (MRK) Price & Performance

Intuitive MachinesTrade
Merck & Co., Inc.Trade

Price performance (Past 24H)

Key statistics

Intuitive Machines vs Merck & Co., Inc. — how do they compare? Intuitive Machines trades at $13.2 (market cap $2.21B), while Merck & Co., Inc. trades at $146.29 (market cap $351.28B). The key difference: Merck & Co., Inc. is far larger — about 159× Intuitive Machines's market cap, and Merck & Co., Inc. pays a 2.39% dividend while Intuitive Machines pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Machines for 5 Days and Merck & Co., Inc. for 98 Days on average.

LUNRMRK
Market Cap
$2.21B$351.28B
Volume
9,284,6147,969,665
Sector
IndustrialsHealth
52-Week High
$45.70$156.43
52-Week Low
$8.05$82.49
Typical Hold Time
5 Days98 Days
Enterprise Value
$2.28B$398.04B
Dividend Yield
—2.39%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Machines

No Aura AI signal available yet.

Merck & Co., Inc.

Merck (MRK) trades at $145.6, up 1.97% today, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, and the company is expanding its oncology pipeline through the acquisition of Terns Pharmaceuticals. Revenue growth is steady, with 2025 revenue at $65.01B and net income of $18.25B, though 2026 projections show a significant drop in net income to $3.2B. The stock is supported by a high analyst buy consensus of 68.42% and a price target of $158.78.

The outlook for MRK is mixed; strong earnings beats and strategic acquisitions provide upside potential, but high valuation ratios and a projected earnings decline in 2026 pose risks. Investors should weigh the company's robust profitability and analyst support against execution risks and market volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LUNR
89% Buy11% Sell
Avg holding period · 5 Days
MRK
60% Buy40% Sell
Avg holding period · 98 Days

Top news

Latest headlines on both assets

About Intuitive Machines

Intuitive Machines provides lunar access, data, and infrastructure services. Its capabilities include lunar landers, communications systems, and technologies designed to support missions to the Moon.

Read more on LUNR →

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Read more on MRK →